Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Latest News

LBank Exchange Will List CURE on January 13, 2022

Published

on

Reading Time: 3 minutes

Internet City, Dubai–(Newsfile Corp. – January 11, 2022) – LBank Exchange, a global digital asset trading platform, will list CURE on January 13, 2022. For all users of LBank Exchange, the CURE/USDT trading pair will be officially available for trading at 22:00 (UTC+8) on January 13, 2022.

Figure 1: LBank Exchange Will List CURE on January 13, 2022

While being used to revolutionize the world, blockchain technology and crypto can be used to heal the world as well. Just like CURE, a community driven project dedicated to using the power of decentralized finance to help rid the planet of dreadful diseases like cancer. Its native token CURE will be listed on LBank Exchange at 22:00 (UTC+8) on January 13, 2022, to further expand its global reach and help it achieve its vision.

Introducing CURE

CURE is a 100% community driven project led by a passionate team of dedicated volunteers and partners who want to make a real difference to the health of everyone on the planet. The project attracts long-term investors who believe in the powerful possibilities when bridging the innovative cryptocurrency space with causes focused on ending modern diseases, beginning with child cancer. Partnering with global research teams and drawing from a wealth of experience in the innovation, technological, and charitable sectors, CURE aims to go one step further than simply becoming the world’s most successful charity token, and to completely revolutionize international healthcare.

The fully doxxed founder of CURE, Jacob Beckley is also the chairman of the highly successful non-profit Beckley Foundation – a charity dedicated to pediatric cancer. CURE is purely philanthropic, and by his own admission Jacob does not want or need to make any personal gains from the project. This echoes the Beckley Foundation itself, which ensures that 100% of the charity’s profits find their way to the direct cause. Jacob is also easily reachable via a variety of means, and always responds to direct messages as soon as he is able. The core team are also doxxed and can be found with a quick Google search.

Unlike many other BSC projects, CURE makes no false, grandiose promises, and is fully committed to achieving everything laid out in the road-map. As the project evolves, investors will be constantly informed of what is happening every step of the way, so they can feel secure in their investment.

About CURE Token

The CURE token is a smart contract based crypto which uses BEP-20 interface, making it secure and immutable. It was initially minted with a supply of 1 billion (i.e. 1,000,000,000) tokens and was fair launched at $200,000 Market Cap with liquidity locked for an initial one year. 372 million tokens of the 1 billion total supply have been burned through transaction tax and manual burns. A further 150 million tokens are locked for 30 days in anticipation for new exchange listing.

CURE has nothing to hide. Everything the project does and hopes to do is clearly outlined, and investor questions are welcomed. Team wallets are not currently locked to allow trading for small profits, but as the project grows they will be time locked. Around $10,000 per day is collected by the charity wallet, which is used for transparent cancer research and sufferer donations. The current contract is NOT renounced, but as the contract is upgraded further down the project’s timeline, it will be. The project lead does not take profit and burns any tokens he buys.

Each transaction of CURE token has a 10% fee subtracted which powers its cause and growth. 4% of it is provided for liquidity to prevent price instability, 3% is allocated to charity wallet, with donations delivered to the custodial non-profit focused on childhood cancer awareness, support and research, and supporting other causes as the project evolved, the rest 3% is for marketing to keep the project growing.

The CURE token will be listed on LBank Exchange at 22:00 (UTC+8) on January 13, 2022, investors who are interested in CURE investment can easily buy and sell CURE on LBank Exchange by then. The listing of CURE on LBank Exchange will undoubtedly help it further expand its business and draw more attention in the market.

Learn More about CURE Token:

Official Website: https://www.curetoken.net/
Telegram: https://t.me/CureTokenV2
Twitter: https://twitter.com/cure_token

About LBank Exchange

LBank Exchange, founded in 2015, is an innovative global trading platform for various crypto assets. LBank Exchange provides its users with safe crypto trading, specialized financial derivatives, and professional asset management services. It has become one of the most popular and trusted crypto trading platforms with over 6.4 million users from now more than 210 regions around the world.

Start Trading Now: lbank.info

Community & Social Media:

Telegram
Twitter
Facebook
Linkedin

Contact Details:

LBK Blockchain Co. Limited
LBank Exchange
[email protected]

PR Contact

ZEXPRWIRE
[email protected]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/109683

Powered by WPeMatico

Latest News

Cortical.io and Swiss Re collaborate to transform insurance document processing

Published

on

 

Cortical.io, renowned for its innovative artificial intelligence (AI) solutions, has teamed up with Swiss Re to advocate for the widespread adoption of intelligent document processing (IDP) among group insurance carriers, streamlining insurance operations.

Through this strategic partnership, Cortical.io’s cutting-edge IDP solution, SemanticPro, will be extended to Swiss Re’s clientele, aiming to expedite the intake process and enhance efficiency in quote preparation and policy comparison.

The intelligent extraction and classification capabilities offered by SemanticPro have demonstrated remarkable improvements in reducing review time and enhancing quote accuracy when compared to traditional manual processes.

This collaboration empowers Swiss Re to better assist its insurance clients by optimizing policy processing workflows, minimizing errors, reducing response times, and improving operational efficiencies.

Chris Howley, Head of Group Life & LTD Reinsurance & Vice President, Americas at Swiss Re, emphasized, “The insurance industry faces challenges with legacy systems, manual workflows, and fragmented data, hindering operational efficiency. Recognizing the need for automation and AI-driven tools to streamline processes and enhance efficiency, we identified Cortical.io as a standout among IDP vendors. Its ability to accurately process complex provisions and its user-friendly, no-code interface set it apart. We eagerly anticipate contributing to our clients’ business success through this collaboration.”

Hans-Peter Riecken, SVP North America at Cortical.io, added, “We are impressed by Swiss Re’s dedication to providing its clients with access to innovative technologies and deeply honored to have been selected to support them in delivering optimal value. It is incredibly rewarding to have our expertise in the insurance industry acknowledged by one of the sector’s leaders, and we are excited to offer Swiss Re’s clients the same benefits enjoyed by our own insurance customer base with Cortical.io SemanticPro.”

Source: fintech.global

The post Cortical.io and Swiss Re collaborate to transform insurance document processing appeared first on HIPTHER Alerts.

Continue Reading

Latest News

GC congratulates NatureWorks and Krungthai Bank on closing a significant financing deal for NatureWorks’ Ingeo PLA Manufacturing Expansion worth 12.6 billion baht, Supporting Thailand’s Ambitious Bio-Circular-Green (BCG) Strategy

Published

on

BANGKOK, May 17, 2024 /PRNewswire/ — Mr. Narongsak Jivakanun (Second from left), CEO of PTT Global Chemical Public Company Limited (GC) presided over the signing ceremony and extended his congratulations to Krungthai Bank and NatureWorks – a joint venture of GC and a leading manufacturer of polylactic acid (PLA) biopolymers made from renewable resources. This is the historic financial support from Krungthai Bank PCL, Thailand’s third largest bank, to optimize the capital structure for the new fully-integrated Ingeo™️ PLA manufacturing facility in Thailand. The financing amounting to $350M USD (12,600M Baht Equivalent), is one of the singular largest loans in the bank’s decades-long history to supporting loans for Green Field project in the Green/Bio businesses. It reinforces GC’s core mission of operating sustainable business practices aligned with the Bio-Circular-Green Economy (BCG) Model for Thailand’s sustainable development.

The funding will not only support the construction of the plant and its ongoing operations but also enables NatureWorks to be competitive in the biomaterials market, pioneering new frontiers for bioplastic applications and advancing biobased solutions with sufficient capacity to capture packaging and fiber customers across the Asia-Pacific region and the rapidly growing global market.

The NatureWorks plant, currently under construction, is the first bio-complex in Thailand, established in line with the government’s BCG economic development strategy, located in Nakhon Sawan province. The project is progressing according to plan, with full-scale production expected to commence in 2025. The plant will have a PLA production capacity of 75,000 tons per year under the Ingeo™️ brand, using locally sourced sugarcane as the primary raw material from local farmers.

For more details, please visit https://www.pttgcgroup.com/en/newsroom/news/1359/

Photo – https://mma.prnewswire.com/media/2415664/Picture_of_Signing_Ceremony.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/gc-congratulates-natureworks-and-krungthai-bank-on-closing-a-significant-financing-deal-for-natureworks-ingeo-pla-manufacturing-expansion-worth-12-6-billion-baht-supporting-thailands-ambitious-bio-circular-green-bcg-strategy-302148699.html

Continue Reading

Latest News

French paytech Lemonway appoints new CTO and CFO

Published

on

 

French payment services provider Lemonway has recently expanded its leadership team with two key appointments in its finance and technology departments, aiming to bolster its management committee. Joining Lemonway’s executive team are Céline Bayer, appointed as Chief Technology Officer (CTO), and Nicolas Vigier, appointed as Chief Financial Officer (CFO).

Céline Bayer’s role as CTO involves streamlining Lemonway’s internal technologies and processes and leveraging artificial intelligence to enhance customer service. With previous experience at AI surveillance software firm Veesion and payment infrastructure firm Mangopay, Bayer brings valuable expertise to her new position.

Meanwhile, Nicolas Vigier takes on the responsibilities of managing Lemonway’s finance and human resources departments as CFO. With prior experience as CFO for merchant payment solution Payplug and roles at payment acceptance and services provider Ingenico Group, Vigier’s financial acumen is expected to contribute significantly to Lemonway’s strategic initiatives.

According to Antoine Orsini, CEO of Lemonway, these appointments mark a milestone in the company’s growth journey. Bayer and Vigier are poised to support Lemonway’s investment efforts aimed at enhancing the security, efficiency, and overall effectiveness of its solutions.

Established in Paris in 2007, Lemonway specializes in providing payment solutions to marketplaces and alternative finance platforms. Their offerings include wallet management, payment processing, and third-party payment capabilities, all within a regulated framework compliant with Know Your Customer (KYC) and Anti-Money Laundering (AML) regulations.

With a client base of over 400 marketplaces and management of more than 1.3 million wallets, Lemonway has emerged as a leader in the payment services industry. To date, the company has raised €50 million in funding, reflecting its strong position in the market.

Source: fintechfutures.com

The post French paytech Lemonway appoints new CTO and CFO appeared first on HIPTHER Alerts.

Continue Reading
Advertisement
Advertisement

Latest news

Trending